Performance of Zika Assays in the Context of Toxoplasma gondii, Parvovirus B19, Rubella Virus, and Cytomegalovirus (TORCH) Diagnostic Assays
-
- Bettie Voordouw
- Erasmus Medical Centre, Department of Viroscience, Rotterdam, The Netherlands
-
- Barry Rockx
- Erasmus Medical Centre, Department of Viroscience, Rotterdam, The Netherlands
-
- Thomas Jaenisch
- Heidelberg University Hospital, Department for Infectious Diseases, Heidelberg, Germany
-
- Pieter Fraaij
- Erasmus Medical Centre, Department of Viroscience, Rotterdam, The Netherlands
-
- Philippe Mayaud
- London School of Hygiene and Tropical Medicine, Department of Clinical Research, London, United Kingdom
-
- Ann Vossen
- Leiden University Medical Centre, Department of Medical Microbiology, Leiden, The Netherlands
-
- Marion Koopmans
- Erasmus Medical Centre, Department of Viroscience, Rotterdam, The Netherlands
書誌事項
- 公開日
- 2019-12-18
- 権利情報
-
- https://journals.asm.org/non-commercial-tdm-license
- DOI
-
- 10.1128/cmr.00130-18
- 公開者
- American Society for Microbiology
この論文をさがす
説明
<jats:p>Infections during pregnancy that may cause congenital abnormalities have been recognized for decades, but their diagnosis is challenging. This was again illustrated with the emergence of Zika virus (ZIKV), highlighting the inherent difficulties in estimating the extent of pre- and postnatal ZIKV complications because of the difficulties in establishing definitive diagnoses.</jats:p>
収録刊行物
-
- Clinical Microbiology Reviews
-
Clinical Microbiology Reviews 33 (1), e00130-18:1-, 2019-12-18
American Society for Microbiology